Literature DB >> 21424282

Karyomegalic-like nephropathy, Ewing's sarcoma and ifosfamide therapy.

Tom McCulloch1, Andrew Prayle, Andy Lunn, Alan R Watson.   

Abstract

Karyomegalic interstitial nephropathy has been reported as a rare interstitial nephritis in adult patients. Histology shows atypical epithelial cells and large abnormal hyperchromatic nuclei with irregular outlines. We report 3 adolescent patients who all recovered from their initial treatment for Ewing's sarcoma but developed a tubulopathy attributed to ifosfamide therapy. Renal impairment resulted in biopsy, which showed features of karyomegalic nephropathy in all 3. One patient has progressed to haemodialysis. Recognition of the pathology may be important in similar patients. It is surmised that the unusual histological findings in these patients stem from a common pathogenesis which may be related to chemotherapeutic agent related nuclear damage. At present there is no specific treatment to prevent progressive renal impairment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21424282     DOI: 10.1007/s00467-011-1815-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System.

Authors:  W Stöhr; M Paulides; S Bielack; H Jürgens; J Treuner; R Rossi; T Langer; J D Beck
Journal:  Pediatr Blood Cancer       Date:  2007-04       Impact factor: 3.167

Review 2.  Karyomegalic interstitial nephritis: report of 3 new cases and review of the literature.

Authors:  G Monga; G Banfi; M Salvadore; O Amatruda; C Bozzola; G Mazzucco
Journal:  Clin Nephrol       Date:  2006-05       Impact factor: 0.975

3.  Karyomegalic nephropathy: an uncommon cause of progressive renal failure.

Authors:  Sunil Bhandari; Steven Kalowski; Paul Collett; Bridget E Cooke; Peter Kerr; Ronald Newland; John Dowling; John Horvath
Journal:  Nephrol Dial Transplant       Date:  2002-11       Impact factor: 5.992

4.  Extreme dysplasia in renal epithelium of a young woman dying from hepatocarcinoma.

Authors:  A F Burry
Journal:  J Pathol       Date:  1974-07       Impact factor: 7.996

5.  Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children.

Authors:  R Loebstein; G Atanackovic; R Bishai; J Wolpin; S Khattak; G Hashemi; M Gobrial; S Baruchel; S Ito; G Koren
Journal:  J Clin Pharmacol       Date:  1999-05       Impact factor: 3.126

6.  Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose.

Authors:  Roderick Skinner; Annie Parry; Lisa Price; Michael Cole; Alan W Craft; Andrew D J Pearson
Journal:  Pediatr Blood Cancer       Date:  2010-07-01       Impact factor: 3.167

7.  Karyomegalic interstitial nephritis: further support for a distinct entity and evidence for a genetic defect.

Authors:  M Spoendlin; H Moch; F Brunner; W Brunner; H R Burger; D Kiss; W Wegmann; P Dalquen; M Oberholzer; G Thiel
Journal:  Am J Kidney Dis       Date:  1995-02       Impact factor: 8.860

8.  Severe renal failure following high-dose ifosfamide and mesna.

Authors:  P H Willemse; P E de Jong; J D Elema; N H Mulder
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

9.  Pathology of high dose intermittent cyclophosphamide therapy.

Authors:  R E Slavin; J C Millan; G M Mullins
Journal:  Hum Pathol       Date:  1975-11       Impact factor: 3.466

10.  Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group.

Authors:  R Skinner; S J Cotterill; M C Stevens
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

View more
  8 in total

1.  Karyomegalic interstitial nephritis.

Authors:  N Bennani Guebessi; M Karkouri
Journal:  CEN Case Rep       Date:  2015-11-24

2.  Improvement in karyomegalic interstitial nephritis three years after ifosfamide and cisplatin therapy by corticosteroid.

Authors:  Tomokazu Matsuura; Shu Wakino; Ayumi Yoshifuji; Toshifumi Nakamura; Hirobumi Tokuyama; Akinori Hashiguchi; Konosuke Konishi; Takeshi Iwasa; Masaaki Shoji; Ako Hosono; Ken Ohashi; Hirokazu Chuman; Hiroshi Itoh
Journal:  CEN Case Rep       Date:  2014-06-04

3.  Genome stability, progressive kidney failure and aging.

Authors:  Hannes Lans; Jan H J Hoeijmakers
Journal:  Nat Genet       Date:  2012-07-27       Impact factor: 38.330

4.  Karyomegalic interstitial nephritis with focal segmental glomerulosclerosis: A rare association.

Authors:  S Radha; A Tameem; B S Rao
Journal:  Indian J Nephrol       Date:  2014-03

5.  Novel Homozygous FAN1 Mutation in a Familial Case of Karyomegalic Interstitial Nephritis.

Authors:  Priyanka J Koshy; Digumarthi V S Sudhakar; Sneha H Anupama; Milly Mathew; Rajeevalochana Parthasarthy; Kumarasamy Thangaraj; Muhammad Magdi Yaqoob; Georgi Abraham
Journal:  Indian J Nephrol       Date:  2020-02-19

Review 6.  Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI.

Authors:  Letizia De Chiara; Gianmarco Lugli; Gianluca Villa; Valentina Raglianti; Faeq Husain-Syed; Fiammetta Ravaglia; Paola Romagnani; Elena Lazzeri
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

7.  Karyomegalic interstitial nephropathy following ifosfamide therapy.

Authors:  R Jayasurya; B H Srinivas; M Ponraj; S Haridasan; S Parameswaran; P S Priyamvada
Journal:  Indian J Nephrol       Date:  2016 Jul-Aug

Review 8.  Karyomegalic Interstitial Nephritis: A Case Report and Review of the Literature.

Authors:  Pierre Isnard; Marion Rabant; Jacques Labaye; Corinne Antignac; Bertrand Knebelmann; Mohamad Zaidan
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.